Fat Cells Lending to New Treatments in Brain Cancer

Regenerative medicines hold incredible potential for new, more potent therapeutics to arrive in the future for a broad spectrum of diseases and conditions. As the industry in general is growing, more possibilities are emerging seemingly on a daily basis as research uncovers new ways to use stem cells to potentially combat deadly diseases like cancer where many patients have little to no hope with todays standards of care.

A recent blog post on the website of American CryoStem, Corp. (OTCQB:CRYO - News) provides some clear information on the MGMT gene and its role in stunting the effectiveness of treating patients with brain cancer, a disease that kills nearly 14,000 people annually. According to the article, research has shown the powerful role that bone marrow stem cells can play as a combination therapy to increase the efficacy and lower toxicity in MGMT-positive brain cancer patients. However, collecting stem cells from bone marrow is a costly and highly invasive process.

New research is outlining the potency of mesenchymal stem cells that are derived from the patients own adipose (fat) tissue that can potentially play a major role in new brain cancer treatments. Doctors arent sure why at this point, but mesenchymal stem cells have an affinity for seeking brain cancer cells and repairing damaged brain tissue.

Additional research is being conducted in other brain-related diseases, such as Parkinsons, that truly offer substantial hope for revolutionary advancements with the disruptive technologies that regenerative medicine is bringing to the table. Notably, Neuralstem, Inc. (NYSE MKT: CUR) is making progress with its stem cell treatment of amyotrophic lateral sclerosis, commonly called Lou Gehrigs disease, with the FDA approving commencement of a Phase II trial under an Orphan Drug designation.

These developments highlight the importance of American CryoStems ATGRAFT program, which facilitates the harvesting and storing of adipose tissue and the associated stem cells. The program offers a form of bio-insurance for individuals against future disease conditions. The companys storage and stem cell processing services can also help feed the research industry with the tools needed to develop cures to some of our most problematic diseases.

Interested parties are encouraged to read the complete blog post at: http://www.americancryostem.com/how-stem-cells-are-being-used-to-fight-brain-cancer/

Sign Up to Follow CRYO here: http://www.emerginggrowthcorp.com/emailassets/cryo/cryo_landing.php

About Emerging Growth LLC

EGC is a marketing and consulting firm that specializes in creating ongoing communications strategies for public and private companies. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx

See more here:
Fat Cells Lending to New Treatments in Brain Cancer